Stock Quote
Angiotech Pharmaceuticals, Inc. (ANP.TO) (Toronto Stock Exchange)
sector: Healthcare .
industry: Medical Equipment, Supplies & Distribution ยท
View ANP on other exchanges
$1.35
23 Nov 2009
-4.26%
$1.41
$1.37
80,050
$1.38
$1.33
$3.10
$0.11
3.79
75,094
ANP.TO
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Howard, David | Chairman of the Board | -- |
| Hunter, William | President, Chief Executive Officer, Director | 1,281,370 |
| Bailey, K.Thomas | Chief Financial Officer | 859,164 |
Profile
Angiotech Pharmaceuticals, Inc. (Angiotech), is a specialty pharmaceutical and medical device company that discovers, develops and markets technologies primarily focused on acute and surgical applications. The Company generates its revenue through the sales of medical products and components, as... Full Description
Company Address
Angiotech Pharmaceuticals, Inc.
1618 Station Street
Vancouver BC V6A 1B6
P: +1604.2217676
F: +1604.2212330
1618 Station Street
Vancouver BC V6A 1B6
P: +1604.2217676
F: +1604.2212330
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Johnson & Johnson | $62.69 | +0.38 |
| Abbott Laboratories | $53.13 | -0.51 |
| Wyeth | -- | -- |
| ANP.TO | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.76 |
| P/S(TTM) | 0.40 | 0.51 |
| ROI(TTM) | -22.97 | 2.54 |
| ROE(TTM) | -- | 4.01 |
| Consensus Recommendation | Underperform |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | 0.06 |
| Total Revenue | $67.72M |
| Net Income | $-8.35M |
| EPS | $-0.10 |
